Medical Cannabis Educational Materials, Resources, Publications and Archives

Final Decision on Medical Cannabis Advisory Board Reports and Recommendations

Medical Cannabis Advisory Board Members

Final decision regarding Advisory Board contained in their report, which was based on the Advisory Board’s findings at a public hearing held on November 3, 2017.

This memo explains the cancellation of the Medical Cannabis Advisory Board meeting scheduled for Friday, May 11.

This memo explains important information and upcoming events.

This memo to Licensed Non-Profit Producers explains that while the application period for new, third party manufactures in the Medical Cannabis Program remains closed, the Department of Health will start accepting requests for amended licenses from LNPPs who are not currently manufacturing for themselves and wish to do so.

This is the letter sent to the New Mexico Medical Society about current vacancies on the Medical Cannabis Program's medical advisory board.

This document explains the petition process for any individual or association of individuals requesting the addition of a new medical condition, medical treatment or disease for the purpose of participating in the medical cannabis program and all lawful privileges under the act.

This memo to Licensed Non-Profit Producers explains that the card extension period which was implemented in the summer of 2016, for cards that expired between June 15 and December 31, 2016 is no longer in effect.

Final decision regarding Advisory Board contained in their report, which was based on the Advisory Board’s findings at a public hearing held on November 4, 2016.

This memo explains the temporary change in enrollment periods for certain persons enrolled in the medical cannabis program to licensed non-profit producers.

This memo explains the temporary change in enrollment periods for certain persons enrolled in the medical cannabis program to law enforcement partners.

This is the report and recommendations to the New Mexico Secretary of Health from the Medical Cannabis Program medical advisory board.

Final decision regarding advisory board report and recommendations from the Medical Cannabis advisory board meeting held on October 30th, 2015.

Proposed changes to NMAC 7.34.4.8 (with markup) which directly affects the Medical Cannabis Program.

List of the proposed rule changes.

On June 16, 2014, the New Mexico Department of Health held a public hearing at the Harold Runnels Building Auditorium in Santa Fe, New Mexico regarding the proposed repeal and replacement of NMAC 7.34.2, NMAC 7.34.3, and NMAC 7.34.4. This report outlines the hearing officer’s report and recommendations.

The purpose of this survey is to determine current patient usage of cannabis and current production of cannabis in New Mexico. Since the Lynn and Erin Compassionate Use Act was passed, the number of patients has increased to 9760. In order to better serve the patients in the program, the New Mexico Department of Health has commissioned this survey to help arrive at approximate levels of usage and production.

This authorization allows the Department of Health (DOH) to disclose confidential health information about you. The authorization may be revoked. It will remain in effect for six (6) months unless a different time is stated. You are entitled to a copy of the completed authorization. There may be fees charged for any copying associated with this request.